Using a well-defined drug-gene pair, we identified an enhancer region for dihydropyrimidine dehydrogenase (DPD, <i>DPYD</i> gene) expression that is relevant to the metabolism of the anti-cancer drug 5-fluorouracil (5-FU). This evidence concerns the gene DPYD and cancer.